David Scheinberg is listed as a director on 3 SEC Form D filings by 2 issuers between Aug 2010 and Jul 2020: CONTRAFECT Corp (Yonkers, NY — biotechnology — 2010–2011; $20M reported sold to 125 investors) and Sapience Therapeutics, Inc. (Harrison, NY — biotechnology — 2020; $8.01M reported sold to 83 investors).
What this means 2 separate companies raised money with this person listed as director, over about 10 years. Across those companies the filings report $28M sold in total.
Listed alongside Cary Sucoff (2 shared filings), Robert C. Nowinski (2 shared filings), Barry Kappel (1 shared filing), Christian Schade (1 shared filing), Howard Pien (1 shared filing) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 court cases matching the name, 3 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for David Scheinberg and found 8 differences: Bankruptcy case: Robert C. Nowinski; 3 court cases name David Scheinberg; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.